Defining treatment‐resistant depression
Background Varying conceptualizations of treatment‐resistant depression (TRD) have made
translating research findings or systematic reviews into clinical practice guidelines …
translating research findings or systematic reviews into clinical practice guidelines …
Depression in the primary care setting
LT Park, CA Zarate Jr - New England Journal of Medicine, 2019 - Mass Medical Soc
Key Clinical Points Depression in the Primary Care Setting Screening for depression and
suicidal thinking and behavior is important in the primary care setting. Distinguishing …
suicidal thinking and behavior is important in the primary care setting. Distinguishing …
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3 …
SH Kennedy, RW Lam, RS McIntyre… - The Canadian …, 2016 - journals.sagepub.com
Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT)
conducted a revision of the 2009 guidelines by updating the evidence and …
conducted a revision of the 2009 guidelines by updating the evidence and …
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …
evidence supplemented by expert clinical consensus and formulate recommendations to …
Do guided internet-based interventions result in clinically relevant changes for patients with depression? An individual participant data meta-analysis
Little is known about clinically relevant changes in guided Internet-based interventions for
depression. Moreover, methodological and power limitations preclude the identification of …
depression. Moreover, methodological and power limitations preclude the identification of …
Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline
Objective To develop an evidence-based guideline to help clinicians make decisions about
when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs); to focus …
when and how to safely taper and stop benzodiazepine receptor agonists (BZRAs); to focus …
Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic …
MT Berlim, F Van den Eynde… - Psychological …, 2014 - cambridge.org
BackgroundMeta-analyses have shown that high-frequency (HF) repetitive transcranial
magnetic stimulation (rTMS) has antidepressant properties when compared with sham …
magnetic stimulation (rTMS) has antidepressant properties when compared with sham …
Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach
RS McIntyre, MJ Filteau, L Martin, S Patry… - Journal of affective …, 2014 - Elsevier
Background Most adults with major depressive disorder (MDD) fail to achieve remission with
index pharmacological treatment. Moreover, at least half will not achieve and sustain …
index pharmacological treatment. Moreover, at least half will not achieve and sustain …
Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder: a randomized clinical trial
RW Lam, AJ Levitt, RD Levitan, EE Michalak… - JAMA …, 2016 - jamanetwork.com
Importance Bright light therapy is an evidence-based treatment for seasonal depression, but
there is limited evidence for its efficacy in nonseasonal major depressive disorder (MDD) …
there is limited evidence for its efficacy in nonseasonal major depressive disorder (MDD) …
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
C Sanchez, EH Reines… - International clinical …, 2014 - journals.lww.com
It is known that newer antidepressants, such as the selective serotonin reuptake inhibitors
(SSRIs), provide advantages in tolerability over antidepressants such as the tricyclics …
(SSRIs), provide advantages in tolerability over antidepressants such as the tricyclics …